Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT01527487
Brief Title: Trial of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast Cancer

First Submitted : January 31, 2012
First Submitted that Met QC Criteria : February 6, 2012
First Posted : February 7, 2012 (Estimate)

Results First Submitted : March 18, 2016
Results First Submitted that Met QC Criteria : July 15, 2016
Results First Posted : August 26, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : October 3, 2016
Last Update Posted : November 4, 2016 (Estimate)